Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/16/2025

Post-CABG Pain Management Guidelines

Introduction to Post-CABG Pain Management

  • The American College of Cardiology and American Heart Association emphasize that optimal analgesia throughout the perioperative period is a Class I recommendation for post-CABG patients 1

Foundation of Pain Management

  • Paracetamol is recommended as baseline treatment for all pain intensities in postoperative multimodal analgesia because it decreases supplementary analgesic requirements 2
  • Paracetamol should be administered at the beginning of postoperative analgesia as it may be better and safer than other drugs 2
  • Maximum dose of paracetamol: 4000 mg/day (reduce to 3000 mg/day in hepatic dysfunction) 3, 4
  • Paracetamol should only be used in combination with other analgesics, never as monotherapy for moderate-severe pain 5, 6

Management of Moderate Pain

  • Tramadol combined with paracetamol is appropriate for WHO Step II (moderate) pain 4
  • The American College of Cardiology suggests avoiding tramadol when possible due to higher delirium risk 1
  • Tramadol has a ceiling effect—increasing doses beyond recommendations increases side effects without proportional pain relief 4

Management of Severe Pain

  • Escalate to strong opioids (morphine or fentanyl) as the primary analgesic for severe pain 1
  • Tramadol is not suitable for severe pain management 4
  • Continue paracetamol as part of multimodal regimen 2

Critical Pitfalls to Avoid

  • Never use COX-2 inhibitors or NSAIDs in post-CABG patients—this is a Class III: HARM recommendation due to increased cardiovascular events 5, 1
  • Avoid excessive opioid dosing which can cause opioid-induced hyperalgesia 1
  • Monitor for tramadol-related delirium, especially in elderly patients 1
  • Screen for seizure history before tramadol use—tramadol lowers seizure threshold 4
  • Check for serotonergic medications—tramadol should not be combined with SSRIs, SNRIs, or MAOIs due to serotonin syndrome risk 4

Monitoring Parameters

  • Assess pain intensity at every encounter using visual analog scales 3
  • Monitor for cognitive changes and delirium (tramadol risk) 4, 1
  • If requiring >4 breakthrough doses daily, escalate baseline therapy 3